Anita P. Wilén-Koort
Keine laufenden Positionen mehr
Profil
Ms Anita Wilén-Koort, Partner and Investment Manager, joined GZ Group in May 2000 and is responsible for identifying and evaluating investment opportunities, managing transactions, investments and GZ Group’s existing portfolio companies.
She has a focus on drug discovery, development, biotech tool suppliers and health care information technology.
Ms Wilén-Koort currently serves as board member in Index Pharmaceuticals AB and deputy board member in Neoventa Medical AB.
Before joining GZ Group, Ms Wilén-Koort held various managerial positions at Pharmacia & Upjohn AB.
During her 15 year long career at Pharmacia she has been working in areas such as Business Control, Corporate Strategic Analysis and Planning and Business Development.
Most recently Ms Wilén-Koort worked as Global Business Intelligence and Marketing Research Manager supporting two different strategic product areas in the company – Urology and Ophthalmology involving global launches of Detrusitol/Detrol and Xalatan, both best selling products in their respective class.
Xalatan has sales exceeding 1 billion USD and Detrusitol/Detrol is expected to reach 1 billion USD in sales in near future.
Ms Wilén-Koort has a B Sc in Business Administration from Uppsala University and an Executive MBA from Stockholm School of Economics.
Ehemalige bekannte Positionen von Anita P. Wilén-Koort
| Unternehmen | Position | Ende |
|---|---|---|
Life Equity Group Holding AB
 Life Equity Group Holding AB Investment ManagersFinance Life Equity Group Holding AB (Life Equity Group) is an independent venture capital firm headquartered in Stockholm, Sweden. The firm was established in 1999 by Lars Gatenbeck and is owned by its partners. | Private Equity Investor | 01.11.2010 |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Direktor/Vorstandsmitglied | - |
| FLERIE INVEST AB | Direktor/Vorstandsmitglied | - |
Ausbildung von Anita P. Wilén-Koort
| University of Uppsala | Undergraduate Degree |
| Stockholm School of Economics | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FLERIE INVEST AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Life Equity Group Holding AB
Life Equity Group Holding AB Investment ManagersFinance Life Equity Group Holding AB (Life Equity Group) is an independent venture capital firm headquartered in Stockholm, Sweden. The firm was established in 1999 by Lars Gatenbeck and is owned by its partners. | Finance |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Health Technology |
